Search

Your search keyword '"Bettencourt Brian"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Bettencourt Brian" Remove constraint Author: "Bettencourt Brian" Database Unpaywall Remove constraint Database: Unpaywall
50 results on '"Bettencourt Brian"'

Search Results

1. Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders

4. A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

6. An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria

7. Phase 2 Open-Label Extension Study (OLE) of Patisiran, an Investigational RNAi Therapeutic for Familial Amyloid Polyneuropathy (FAP) (S38.003)

8. Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis

9. ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients

10. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis

11. Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

12. Rapid progression of familial amyloidotic polyneuropathy

13. Phase 2 open-label extension study of patisiran, an investigational RNAi therapeutic for the treatment of familial amyloid polyneuropathy (S9.003)

14. Abstract 666: RNAi Therapeutics Targeting Human Angiotensinogen (hAGT) Ameliorate Preeclamptic Sequelae in an Established Transgenic Rodent Model for Preeclampsia

16. 850c RNAi Therapeutics Ameliorate Liver Disease Associated with Alpha-1-Antitrypsin Deficiency

17. Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

19. Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

21. Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals

26. Thienopyrrole acetic acids as antagonists of the CRTH2 receptor

27. In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)

30. Rotationally Constrained 2,4-Diamino-5,6-disubstituted Pyrimidines: A New Class of Histamine H4Receptor Antagonists with Improved Druglikeness and in Vivo Efficacy in Pain and Inflammation Models

31. Structure−Activity Studies on a Series of a 2-Aminopyrimidine-Containing Histamine H4Receptor Ligands

32. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists

36. Comparative genome sequencing of Drosophila pseudoobscura: Chromosomal, gene, and cis-element evolution

48. Conformational Integrity and Ligand Binding Properties of a Single Chain T-cell Receptor Expressed in Escherichia coli

49. Affinity and kinetics of the interactions between an αβ T-cell receptor and its superantigen and class II-MHC/peptide ligands

50. Pleiotropic Effects of Vitamin D on Osteoblast Gene Expression Are Related to the Proliferative and Differentiated State of the Bone Cell Phenotype: Dependency upon Basal Levels of Gene Expression, Duration of Exposure, and Bone Matrix Competency in Normal Rat Osteoblast Cultures*

Catalog

Books, media, physical & digital resources